A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion

ConditionsAcute Ischemic Stroke Endovascular Thrombectomy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorThe First Affiliated Hospital of University of Science and Technology of China

About this trial

To Evaluate the Safety and Efficacy of the Super-Bore 8/7F Thrombosis Aspiration Catheter in the Treatment of Acute Intracranial Large Vessel Occlusion.

Eligibility criteria

Qualifiers

Aged 18 years or older;

Clinical presentation consistent with acute ischemic stroke (AIS);

Able to receive mechanical thrombectomy within 24 hours of onset;

Pre-morbid mRS score of 0 or 1;

Disqualifiers

Pregnant or lactating women;

Severe allergic reactions to contrast agents;

Current participation in other clinical studies;

Known hereditary or acquired bleeding disorders, platelet count <50,000/µL, or coagulation factor deficiencies;

Trial design

Treatments tested in this trial

Super-Bore Thrombosis Aspiration Catheter treatment group
Conventional thrombectomy device treatment group

Treatment groups

360 Participants

are divided into 2 treatment groups

Sponsors and collaborators

The First Affiliated Hospital of University of Science and Technology of China

Lead sponsor

Source ClinicalTrials.gov